The Food and Drug Administration is considering adding warning labels to antidepressants for people who are pregnant, despite ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications like fluoxetine (Prozac), sertraline (Zoloft) and citalopram (Celexa), among ...

Democrats have accused Robert Kennedy Jr. of making claims without scientific research to back them and say his claims are ...

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...

A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted to ...

Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...

Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ ...

An Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...

NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...